The Global Resource For Connecting Buyers and Sellers

Protext Mobility Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License

BOCA RATON, FL–(Marketwired – May 23, 2017) – Protext Pharma, Inc. (OTC PINK: TXTM) (“Protext” or “the Company”), a biotech company engaged in the development of pharmaceutical applications with highly bioavailable Phytofare® extracts, has announced today that its name change to Protext Pharma, Inc is now effective with the State of Delaware, and is pleased to provide the following shareholders update on its wholly owned subsidiary Cannabis Biosciences. The Company expects to submit the name change to FINRA in the coming days.